Biznesradar Premium czy Biznesradar Plus?
od którego produktu zacząć?
SPRAWDŹWskaźniki wartości rynkowej CLN (CLNPHARMA)
42.50+1.90(+4.68%)CELON PHARMA SPÓŁKA AKCYJNA
GPW - Akcje - Notowania ciągłe
| 2012/Q4 (gru 12) | 2013/Q4 (gru 13) | 2014/Q4 (gru 14) | 2015/Q4 (gru 15) | 2016/Q3 (wrz 16) | 2016/Q4 (gru 16) | 2017/Q1 (mar 17) | 2017/Q2 (cze 17) | 2017/Q3 (wrz 17) | 2017/Q4 (gru 17) | 2018/Q1 (mar 18) | 2018/Q2 (cze 18) | 2018/Q3 (wrz 18) | 2018/Q4 (gru 18) | 2019/Q1 (mar 19) | 2019/Q2 (cze 19) | 2019/Q3 (wrz 19) | 2019/Q4 (gru 19) | 2020/Q1 (mar 20) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kurs | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | 42.50 | |
| Liczba akcji | 30 000 000 | 30 000 000 | 30 000 000 | 30 000 000 | 30 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | 45 000 000 | |
| Wartość księgowa na akcję | 1.20 | 1.74 r/r +44.86% | 2.32 r/r +33.36% | 3.36 r/r +44.82% | 4.38 | 8.94 r/r +166.16% k/k +104.11% | 9.06 k/k +1.26% | 9.30 k/k +2.71% | 9.43 r/r +115.30% k/k +1.42% | 9.77 r/r +9.28% k/k +3.60% | 9.94 r/r +9.78% k/k +1.72% | 9.95 r/r +7.01% k/k +0.12% | 10.07 r/r +6.75% k/k +1.18% | 9.97 r/r +2.02% k/k -0.99% | 10.12 r/r +1.75% k/k +1.45% | 9.83 r/r -1.26% k/k -2.84% | 9.89 r/r -1.83% k/k +0.60% | 9.89 r/r -0.82% k/k +0.03% | 9.46 r/r -6.53% k/k -4.39% | |
| Cena / Wartość księgowa | 35.38~sektor 4.94 | 24.42~sektor 2.50 r/r -30.97%~sektor -49.34% | 18.31~sektor 2.30 r/r -25.02%~sektor -8.11% | 12.65~sektor 2.44 r/r -30.95%~sektor +6.36% | 9.70~sektor 2.01 | 4.75~sektor 2.32 r/r -62.43%~sektor -4.92% k/k -51.01%~sektor +15.82% | 4.69~sektor 1.98 k/k -1.24%~sektor -14.95% | 4.57~sektor 2.00 k/k -2.64%~sektor +1.10% | 4.50~sektor 1.93 r/r -53.55%~sektor -3.74% k/k -1.40%~sektor -3.34% | 4.35~sektor 1.97 r/r -8.49%~sektor -15.31% k/k -3.48%~sektor +1.89% | 4.27~sektor 1.90 r/r -8.91%~sektor -3.96% k/k -1.69%~sektor -3.54% | 4.27~sektor 1.91 r/r -6.54%~sektor -4.42% k/k -0.12%~sektor +0.62% | 4.22~sektor 1.91 r/r -6.32%~sektor -1.02% k/k -1.16%~sektor +0.09% | 4.26~sektor 1.91 r/r -1.98%~sektor -2.69% k/k +1.00%~sektor +0.17% | 4.20~sektor 1.86 r/r -1.72%~sektor -1.81% k/k -1.42%~sektor -2.67% | 4.32~sektor 1.86 r/r +1.28%~sektor -2.58% k/k +2.93%~sektor -0.18% | 4.30~sektor 1.78 r/r +1.87%~sektor -6.65% k/k -0.59%~sektor -4.08% | 4.30~sektor 1.86 r/r +0.83%~sektor -2.70% k/k -0.03%~sektor +4.41% | 4.49~sektor 1.95 r/r +6.98%~sektor +4.43% k/k +4.59%~sektor +4.46% | |
| Wartość księgowa Grahama na akcję | 0.37 | 0.58 r/r +55.56% | 0.42 r/r -27.46% | 0.34 r/r -18.05% | 0.78 | 5.71 r/r +1564.25% k/k +630.12% | 5.72 k/k +0.22% | 5.48 k/k -4.25% | 5.40 r/r +590.77% k/k -1.40% | 5.31 r/r -7.02% k/k -1.72% | 5.02 r/r -12.37% k/k -5.56% | 4.72 r/r -13.97% k/k -6.00% | 4.48 r/r -17.14% k/k -5.03% | 4.41 r/r -17.05% k/k -1.62% | 4.23 r/r -15.71% k/k -4.02% | 3.44 r/r -27.02% k/k -18.62% | 2.96 r/r -33.81% k/k -13.87% | 2.76 r/r -37.38% k/k -6.92% | 2.32 r/r -45.18% k/k -15.99% | |
| Cena / Wartość księgowa Grahama | 114.52~sektor 20.32 | 73.62~sektor 13.97 r/r -35.72%~sektor -31.24% | 101.47~sektor 14.80 r/r +37.84%~sektor +5.91% | 123.82~sektor 21.39 r/r +22.03%~sektor +44.56% | 54.33~sektor 11.52 | 7.44~sektor 12.66 r/r -93.99%~sektor -40.84% k/k -86.30%~sektor +9.85% | 7.42~sektor 7.42 k/k -0.22%~sektor -41.34% | 7.75~sektor 7.75 k/k +4.44%~sektor +4.44% | 7.86~sektor 7.86 r/r -85.52%~sektor -31.74% k/k +1.42%~sektor +1.42% | 8.00~sektor 20.78 r/r +7.54%~sektor +64.20% k/k +1.75%~sektor +164.26% | 8.47~sektor 8.09 r/r +14.12%~sektor +8.90% k/k +5.88%~sektor -61.10% | 9.01~sektor 6.90 r/r +16.24%~sektor -10.96% k/k +6.38%~sektor -14.61% | 9.49~sektor 7.76 r/r +20.69%~sektor -1.33% k/k +5.30%~sektor +12.39% | 9.65~sektor 8.42 r/r +20.56%~sektor -59.48% k/k +1.64%~sektor +8.52% | 10.05~sektor 4.90 r/r +18.63%~sektor -39.35% k/k +4.19%~sektor -41.77% | 12.35~sektor 6.33 r/r +37.03%~sektor -8.35% k/k +22.88%~sektor +29.05% | 14.34~sektor 6.63 r/r +51.08%~sektor -14.62% k/k +16.10%~sektor +4.69% | 15.41~sektor 11.68 r/r +59.68%~sektor +38.70% k/k +7.43%~sektor +76.30% | 18.34~sektor 7.56 r/r +82.43%~sektor +54.17% k/k +19.03%~sektor -35.27% | |
| Przychody ze sprzedaży na akcję | 1.34 | 2.39 r/r +78.61% | 3.27 r/r +36.93% | 3.58 r/r +9.62% | 3.71 | 2.86 r/r -20.17% k/k -22.82% | 2.56 k/k -10.43% | 2.82 k/k +10.04% | 2.86 r/r -22.84% k/k +1.43% | 2.38 r/r -16.82% k/k -16.80% | 2.38 r/r -7.32% k/k -0.20% | 2.41 r/r -14.49% k/k +1.52% | 2.58 r/r -9.89% k/k +6.90% | 2.78 r/r +16.92% k/k +7.96% | 2.76 r/r +16.15% k/k -0.86% | 2.62 r/r +8.82% k/k -4.89% | 2.45 r/r -4.84% k/k -6.52% | 2.27 r/r -18.36% k/k -7.38% | 2.36 r/r -14.62% k/k +3.68% | |
| Cena / Przychody ze sprzedaży | 31.79~sektor 2.66 | 17.80~sektor 2.34 r/r -44.01%~sektor -11.80% | 13.00~sektor 2.40 r/r -26.97%~sektor +2.57% | 11.86~sektor 2.46 r/r -8.78%~sektor +2.34% | 11.46~sektor 2.45 | 14.85~sektor 4.04 r/r +25.26%~sektor +64.26% k/k +29.57%~sektor +64.84% | 16.58~sektor 2.35 k/k +11.65%~sektor -41.80% | 15.07~sektor 3.31 k/k -9.12%~sektor +41.03% | 14.86~sektor 3.45 r/r +29.60%~sektor +40.91% k/k -1.41%~sektor +4.15% | 17.85~sektor 2.74 r/r +20.22%~sektor -32.12% k/k +20.18%~sektor -20.60% | 17.89~sektor 2.69 r/r +7.90%~sektor +14.67% k/k +0.21%~sektor -1.68% | 17.62~sektor 2.67 r/r +16.95%~sektor -19.57% k/k -1.50%~sektor -1.07% | 16.49~sektor 2.39 r/r +10.97%~sektor -30.89% k/k -6.45%~sektor -10.51% | 15.27~sektor 2.13 r/r -14.47%~sektor -22.27% k/k -7.37%~sektor -10.70% | 15.40~sektor 1.98 r/r -13.91%~sektor -26.37% k/k +0.87%~sektor -6.87% | 16.19~sektor 2.02 r/r -8.10%~sektor -24.19% k/k +5.14%~sektor +1.86% | 17.32~sektor 2.01 r/r +5.09%~sektor -15.83% k/k +6.97%~sektor -0.64% | 18.70~sektor 7.22 r/r +22.49%~sektor +238.90% k/k +7.97%~sektor +259.57% | 18.04~sektor 1.85 r/r +17.13%~sektor -6.54% k/k -3.55%~sektor -74.32% | |
| Zysk na akcję | 0.04 | 0.60 r/r +1248.20% | 1.74 r/r +190.71% | 1.24 r/r -28.78% | 1.41 | 0.84 r/r -32.20% k/k -40.48% | 0.60 k/k -28.08% | 0.52 k/k -14.08% | 0.49 r/r -65.21% k/k -5.39% | 0.57 r/r -32.25% k/k +15.88% | 0.63 r/r +4.07% k/k +10.49% | 0.61 r/r +16.93% k/k -3.47% | 0.66 r/r +34.24% k/k +8.61% | 0.66 r/r +15.93% k/k +0.08% | 0.64 r/r +1.19% k/k -3.56% | 0.50 r/r -16.83% k/k -20.66% | 0.37 r/r -44.19% k/k -27.11% | 0.27 r/r -59.81% k/k -27.93% | 0.33 r/r -48.11% k/k +24.51% | |
| Cena / Zysk | 956.49~sektor 19.93 | 71.00~sektor 19.90 r/r -92.58%~sektor -0.15% | 24.42~sektor 35.28 r/r -65.60%~sektor +77.31% | 34.29~sektor 34.29 r/r +40.42%~sektor -2.80% | 30.10~sektor 30.10 | 50.59~sektor 50.59 r/r +47.51%~sektor +47.51% k/k +68.03%~sektor +68.03% | 70.33~sektor 47.84 k/k +39.03%~sektor -5.43% | 81.85~sektor 44.60 k/k +16.38%~sektor -6.77% | 86.52~sektor 49.16 r/r +187.39%~sektor +63.28% k/k +5.70%~sektor +10.22% | 74.66~sektor 74.66 r/r +47.60%~sektor +47.60% k/k -13.70%~sektor +51.89% | 67.57~sektor 44.78 r/r -3.91%~sektor -6.40% k/k -9.49%~sektor -40.03% | 70.00~sektor 29.16 r/r -14.48%~sektor -34.63% k/k +3.59%~sektor -34.89% | 64.45~sektor 27.03 r/r -25.50%~sektor -45.02% k/k -7.92%~sektor -7.31% | 64.40~sektor 19.39 r/r -13.75%~sektor -74.03% k/k -0.08%~sektor -28.25% | 66.78~sektor 16.08 r/r -1.17%~sektor -64.09% k/k +3.70%~sektor -17.07% | 84.18~sektor 19.33 r/r +20.25%~sektor -33.69% k/k +26.04%~sektor +20.23% | 115.48~sektor 20.67 r/r +79.16%~sektor -23.52% k/k +37.18%~sektor +6.92% | 160.24~sektor 62.36 r/r +148.82%~sektor +221.61% k/k +38.77%~sektor +201.70% | 128.72~sektor 48.16 r/r +92.74%~sektor +199.53% k/k -19.67%~sektor -22.77% | |
| Zysk operacyjny na akcję | 0.08 | 0.74 r/r +772.31% | 0.99 r/r +34.81% | 0.61 r/r -38.78% | 0.78 | 1.05 r/r +71.91% k/k +33.93% | 0.73 k/k -30.02% | 0.62 k/k -15.86% | 0.51 r/r -34.13% k/k -16.47% | 0.58 r/r -44.76% k/k +12.31% | 0.64 r/r -12.05% k/k +11.43% | 0.68 r/r +9.96% k/k +5.19% | 0.76 r/r +48.24% k/k +12.61% | 0.79 r/r +37.02% k/k +3.80% | 0.76 r/r +18.18% k/k -3.89% | 0.55 r/r -18.71% k/k -27.65% | 0.41 r/r -46.67% k/k -26.11% | 0.15 r/r -80.63% k/k -62.30% | 0.22 r/r -71.21% k/k +42.86% | |
| Cena / Zysk operacyjny | 502.76~sektor 15.48 | 57.66~sektor 15.21 r/r -88.53%~sektor -1.77% | 42.77~sektor 17.48 r/r -25.83%~sektor +14.95% | 69.86~sektor 22.27 r/r +63.35%~sektor +27.42% | 54.43~sektor 40.40 | 40.64~sektor 22.52 r/r -41.83%~sektor +1.13% k/k -25.33%~sektor -44.25% | 58.07~sektor 41.46 k/k +42.89%~sektor +84.10% | 69.03~sektor 43.93 k/k +18.86%~sektor +5.94% | 82.63~sektor 48.05 r/r +51.81%~sektor +18.95% k/k +19.72%~sektor +9.40% | 73.58~sektor 40.11 r/r +81.05%~sektor +78.09% k/k -10.95%~sektor -16.53% | 66.03~sektor 16.51 r/r +13.70%~sektor -60.19% k/k -10.26%~sektor -58.84% | 62.78~sektor 22.30 r/r -9.05%~sektor -49.24% k/k -4.93%~sektor +35.08% | 55.75~sektor 23.15 r/r -32.54%~sektor -51.82% k/k -11.20%~sektor +3.84% | 53.71~sektor 22.59 r/r -27.01%~sektor -43.68% k/k -3.66%~sektor -2.44% | 55.88~sektor 22.14 r/r -15.37%~sektor +34.08% k/k +4.05%~sektor -2.02% | 77.23~sektor 22.14 r/r +23.02%~sektor -0.72% k/k +38.20%~sektor +0.02% | 104.53~sektor 19.04 r/r +87.52%~sektor -17.76% k/k +35.35%~sektor -13.99% | 277.29~sektor 30.74 r/r +416.33%~sektor +36.05% k/k +165.27%~sektor +61.41% | 194.04~sektor 29.45 r/r +247.25%~sektor +33.03% k/k -30.02%~sektor -4.19% | |
| Enterprise Value na akcję | 42.32 | 42.33 r/r +0.03% | 42.60 r/r +0.64% | 42.83 r/r +0.53% | 42.48 | 37.73 r/r -11.89% k/k -11.17% | 37.54 k/k -0.51% | 37.85 k/k +0.81% | 37.95 r/r -10.67% k/k +0.26% | 38.10 r/r +0.97% k/k +0.40% | 38.17 r/r +1.68% k/k +0.20% | 38.30 r/r +1.19% k/k +0.32% | 38.97 r/r +2.70% k/k +1.76% | 39.26 r/r +3.04% k/k +0.74% | 39.26 r/r +2.83% k/k -0.01% | 40.13 r/r +4.79% k/k +2.23% | 40.76 r/r +4.60% k/k +1.58% | 41.05 r/r +4.57% k/k +0.71% | 41.29 r/r +5.18% k/k +0.57% | |
| EV / Przychody ze sprzedaży | 31.65~sektor 2.63 | 17.73~sektor 2.15 r/r -44.00%~sektor -18.03% | 13.03~sektor 2.30 r/r -26.51%~sektor +6.88% | 11.95~sektor 2.43 r/r -8.30%~sektor +5.44% | 11.46~sektor 2.40 | 13.19~sektor 4.00 r/r +10.36%~sektor +64.83% k/k +15.09%~sektor +66.65% | 14.65~sektor 2.33 k/k +11.08%~sektor -41.67% | 13.42~sektor 3.38 k/k -8.38%~sektor +44.67% | 13.26~sektor 3.67 r/r +15.77%~sektor +52.70% k/k -1.16%~sektor +8.58% | 16.01~sektor 2.64 r/r +21.39%~sektor -33.90% k/k +20.67%~sektor -27.87% | 16.07~sektor 2.82 r/r +9.71%~sektor +20.98% k/k +0.40%~sektor +6.77% | 15.88~sektor 2.85 r/r +18.34%~sektor -15.59% k/k -1.18%~sektor +0.94% | 15.12~sektor 2.50 r/r +13.97%~sektor -31.91% k/k -4.81%~sektor -12.41% | 14.11~sektor 2.40 r/r -11.87%~sektor -9.17% k/k -6.68%~sektor -3.78% | 14.23~sektor 2.60 r/r -11.47%~sektor -7.86% k/k +0.86%~sektor +8.31% | 15.29~sektor 2.64 r/r -3.70%~sektor -7.25% k/k +7.49%~sektor +1.60% | 16.62~sektor 2.65 r/r +9.92%~sektor +6.20% k/k +8.66%~sektor +0.29% | 18.07~sektor 7.75 r/r +28.10%~sektor +222.84% k/k +8.74%~sektor +192.52% | 17.53~sektor 2.44 r/r +23.19%~sektor -6.23% k/k -3.01%~sektor -68.54% | |
| EV / EBIT | 500.62~sektor 8.52 | 57.43~sektor 12.08 r/r -88.53%~sektor +41.71% | 42.87~sektor 12.52 r/r -25.36%~sektor +3.62% | 70.40~sektor -2.05 r/r +64.21%~sektor -116.34% | 54.40~sektor 3.21 | 36.08~sektor -12.04 r/r -48.74%~sektor -488.64% k/k -33.67%~sektor -474.99% | 51.30~sektor -5.14 k/k +42.17%~sektor +57.29% | 61.47~sektor -6.15 k/k +19.82%~sektor -19.52% | 73.78~sektor -5.64 r/r +35.62%~sektor -275.72% k/k +20.03%~sektor +8.20% | 65.96~sektor 10.92 r/r +82.81%~sektor +190.73% k/k -10.59%~sektor +293.62% | 59.31~sektor 5.98 r/r +15.62%~sektor +216.28% k/k -10.09%~sektor -45.26% | 56.57~sektor 13.19 r/r -7.97%~sektor +314.67% k/k -4.63%~sektor +120.64% | 51.11~sektor -1.11 r/r -30.72%~sektor +80.40% k/k -9.64%~sektor -108.38% | 49.61~sektor -5.66 r/r -24.79%~sektor -151.78% k/k -2.94%~sektor -411.50% | 51.61~sektor -4.50 r/r -12.98%~sektor -175.28% k/k +4.04%~sektor +20.42% | 72.92~sektor -2.98 r/r +28.91%~sektor -122.55% k/k +41.29%~sektor +33.90% | 100.26~sektor -4.66 r/r +96.15%~sektor -321.05% k/k +37.49%~sektor -56.50% | 267.87~sektor -2.84 r/r +439.94%~sektor +49.83% k/k +167.17%~sektor +39.05% | 188.51~sektor 2.46 r/r +265.23%~sektor +154.75% k/k -29.63%~sektor +186.84% | |
| EV / EBITDA | 175.36~sektor 5.74 | 47.44~sektor 10.02 r/r -72.95%~sektor +74.68% | 36.65~sektor 9.13 r/r -22.73%~sektor -8.91% | 48.64~sektor 7.70 r/r +32.69%~sektor -15.69% | 34.90~sektor 2.72 | 28.11~sektor 9.31 r/r -42.21%~sektor +21.02% k/k -19.47%~sektor +241.82% | 35.11~sektor 9.66 k/k +24.90%~sektor +3.74% | 41.05~sektor -2.26 k/k +16.93%~sektor -123.38% | 45.69~sektor -2.41 r/r +30.91%~sektor -188.57% k/k +11.31%~sektor -6.84% | 39.64~sektor 9.77 r/r +41.02%~sektor +4.88% k/k -13.24%~sektor +504.77% | 36.60~sektor 8.59 r/r +4.26%~sektor -11.09% k/k -7.66%~sektor -12.05% | 35.20~sektor 10.89 r/r -14.25%~sektor +582.23% k/k -3.83%~sektor +26.79% | 32.97~sektor 8.59 r/r -27.83%~sektor +456.08% k/k -6.32%~sektor -21.11% | 33.44~sektor 0.97 r/r -15.63%~sektor -90.04% k/k +1.42%~sektor -88.67% | 33.89~sektor -5.56 r/r -7.40%~sektor -164.78% k/k +1.34%~sektor -671.76% | 41.62~sektor -3.56 r/r +18.23%~sektor -132.70% k/k +22.79%~sektor +36.00% | 48.47~sektor -5.68 r/r +47.01%~sektor -166.09% k/k +16.47%~sektor -59.46% | 67.14~sektor -3.21 r/r +100.75%~sektor -429.63% k/k +38.50%~sektor +43.51% | 60.59~sektor 1.39 r/r +78.76%~sektor +125.03% k/k -9.76%~sektor +143.42% |
* Zaznaczając tę opcję uwzględniany jest jedynie aktualny kurs akcji. W przeciwnym wypadku przy obliczaniu wskaźników uwzględniany jest kurs akcji z dnia daty bilansowej raportu finansowego.
Wskaźniki obliczane są na podstawie urocznionych wartości RZiS i PP z 4 ostatnich raportów kwartalnych.
Wartości dla sektora obliczane są w oparciu o medianę.
Wskaźniki obliczane są na podstawie urocznionych wartości RZiS i PP z 4 ostatnich raportów kwartalnych.
Wartości dla sektora obliczane są w oparciu o medianę.
Informacje
| ISIN: | PLCLNPH00015 |
|---|---|
| Liczba akcji: | 45 000 000 |
| Kapitalizacja: | 1 912 500 000 |
| Sektor: | GPW: Przemysł farmaceutyczny |
Celon Pharma jest spółką biofarmaceutyczną zajmującą się badaniami, rozwojem, wytwarzaniem oraz sprzedażą produktów farmaceutycznych. Dysponuje... Celon Pharma jest spółką biofarmaceutyczną zajmującą się badaniami, rozwojem, wytwarzaniem oraz sprzedażą produktów farmaceutycznych. Dysponuje własnym laboratorium badawczo-rozwojowym, gdzie rozwija własne technologie farmaceutyczne. Spółka posiada również zakład wytwórczy, w którym wytwarzane są suche formy farmaceutyczne.
| Nazwa: | CELON PHARMA SPÓŁKA AKCYJNA |
|---|---|
| Adres: | ul. Ogrodowa 2A, 05-092, Kiełpin, POLSKA |
| CEO: | Maciej Wieczorek |
| NIP: | 1181642061 |
| REGON: | 015181033 |
| KRS: | 0000437778 |
| Telefon: | +48 (22) 751 59 33 |
| WWW: | http://celonpharma.com/ |
